8-K:臨時報告書
D:発行のお知らせ
8-K:臨時報告書
10-Q:Q1 2024 四半期報告書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 10-K:FY 2023 年度報告書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 424B3:目論見書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 424B3:目論見書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 10-Q/A:四半期報告書(訂正)
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 10-Q/A:四半期報告書(訂正)
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 10-Q/A:四半期報告書(訂正)
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 10-K/A:FY 2021 年度報告書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 8-K:臨時報告書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | SC 13G:大量保有報告書-Armistice Capital, LLC(9.96%),Steven Boyd(9.96%)
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 424B3:目論見書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 424B3:目論見書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 8-K:臨時報告書
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 4:インサイダー売買報告書-執行役 Cogley Brian
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 3:インサイダー登録報告書-執行役 Cogley Brian
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | 4:インサイダー売買報告書-取締役 DeSilva Tara
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) | SCHEDULE 13G:その他
データなし